102
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Stroke Recurrence Rate and Risk Factors Among Stroke Survivors in Sub-Saharan Africa: A Systematic Review

ORCID Icon, ORCID Icon, , , , ORCID Icon, , , & show all
Pages 783-791 | Received 20 Nov 2023, Accepted 22 Mar 2024, Published online: 02 Apr 2024

References

  • World Health Organisation. The top 10 causes of death; 2020.
  • Fm OMAAA, Ogbera AO, Laarje A. Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns. Pan Afr Med J. 2016;25:75. doi:10.11604/pamj.2016.25.75.8797
  • O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi:10.1016/S0140-6736(16)30506-2
  • Maredza M, Bertram MY, Gomez-Olive XF, Tollman SM. Burden of stroke attributable to selected lifestyle risk factors in rural South Africa. BMC Public Health. 2016;16(1):143. doi:10.1186/s12889-016-2805-7
  • Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42(5):1489–1494.
  • Collaboration AT; Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. J Bmj. 2002;324(7329):71–86. doi:10.1136/bmj.324.7329.71
  • Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med. 2009;2(1):30. doi:10.1186/1755-7682-2-30
  • Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;2015(3):CD000024. doi:10.1002/14651858.CD000024.pub4
  • Ni Chroinin D, Asplund K, Asberg S, et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013;44(2):448–456. doi:10.1161/STROKEAHA.112.668277
  • Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
  • Arboix A, Massons J, Garcia-Eroles L, et al. Nineteen-year trends in risk factors, clinical characteristics and prognosis in lacunar infarcts. Neuroepidemiology. 2010;35(3):231–236. doi:10.1159/000319460
  • Loeb C, Gandolfo C, Croce R, Conti M. Dementia associated with lacunar infarction. Stroke. 1992;23(9):1225–1229. doi:10.1161/01.STR.23.9.1225
  • Arboix A, Oliveres M, Massons J, Pujades R, Garcia-Eroles L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol. 1999;6(6):677–683. doi:10.1046/j.1468-1331.1999.660677.x
  • Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study. Lancet. 2014;383(9913):245–254. doi:10.1016/S0140-6736(13)61953-4
  • Adoukonou T, Kossi O, Fotso Mefo P, et al. Stroke case fatality in sub-Saharan Africa: systematic review and meta-analysis. Int J Stroke. 2021;16(8):902–916. doi:10.1177/1747493021990945
  • Owolabi MO, Akarolo-Anthony S, Akinyemi R, et al. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr. 2015;26(2 Suppl 1):S27–38. doi:10.5830/CVJA-2015-038
  • Akinyemi RO, Owolabi MO, Ihara M, et al. Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa. Brain Res Bull. 2019;145:97–108. doi:10.1016/j.brainresbull.2018.05.018
  • Walker R, Whiting D, Unwin N, et al. Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol. 2010;9(8):786–792. doi:10.1016/S1474-4422(10)70144-7
  • Lekoubou A, Nkoke C, Dzudie A, Kengne AP. Stroke admission and case-fatality in an urban medical unit in sub-Saharan Africa: a fourteen year trend study from 1999 to 2012. J Neurol Sci. 2015;350(1–2):24–32. doi:10.1016/j.jns.2015.02.002
  • Akinyemi RO, Ovbiagele B, Adeniji OA, et al. Stroke in Africa: profile, progress, prospects and priorities. Nat Rev Neurol. 2021;17(10):634–656. doi:10.1038/s41582-021-00542-4
  • None N. Sub-Saharan Africa. Glob Heart. 2018;13(3):171–175. doi:10.1016/j.gheart.2018.09.514
  • Furlan AD, Malmivaara A, Chou R, et al. Updated method guideline for systematic reviews in the Cochrane back and neck group. Spine. 2015;40(21):1660–1673. doi:10.1097/BRS.0000000000001061
  • Li T, Vedula SS, Hadar N, Parkin C, Lau J, Dickersin K. Innovations in data collection, management, and archiving for systematic reviews. Ann Intern Med. 2015;162(4):287–294. doi:10.7326/M14-1603
  • Dabilgou AA, Drave A, Kyelem JMA, et al. Frequency of recurrent stroke in Burkina Faso: an observational hospital based study of 6 months. Pan Afr Med J. 2021;40:108. doi:10.11604/pamj.2021.40.108.23098
  • Akpalu A, Sarfo FS, Akinyemi J, et al. Frequency & factors associated with recurrent stroke in Ghana and Nigeria. J Neurol Sci. 2022;439:120303. doi:10.1016/j.jns.2022.120303
  • Walker RW, Jusabani A, Aris E, et al. Stroke risk factors in an incident population in urban and rural Tanzania: a prospective, community-based, case-control study. Lancet Glob Health. 2013;1(5):e282–8. doi:10.1016/S2214-109X(13)70068-8
  • Kamgang J, Tetinou F, Zolo Y, et al. Recurrent ischemic and hemorrhagic stroke in Cameroon: a case-control study. Neurol Res Int. 2021;2021:9948990. doi:10.1155/2021/9948990
  • Lekoubou A, Nkoke C, Dzudie A, Kengne AP. Recurrent stroke and early mortality in an urban medical unit in Cameroon. J Stroke Cerebrovasc Dis. 2017;26(8):1689–1694. doi:10.1016/j.jstrokecerebrovasdis.2017.03.031
  • Mbonda PC, Mafo D, Doumbe J, Kuate C. Recurrence of strokes and associated factors at laquintinie hospital in douala. Clinical Neur Neuro sci. 2021;5:3. doi:10.11648/j.cnn.20210503.12
  • Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1–5. doi:10.1159/000352050
  • Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012;43(10):2592–2597. doi:10.1161/STROKEAHA.112.661603
  • Thorogood M, Connor M, Lewando-Hundt G, Tollman S, Ngoma B. Team SPJBotWHO. Secon Preven Stroke. 2004;82(7):503.
  • Wasserman S, De Villiers L, Ajsamj B. Community-based care of stroke patients in a rural African setting. South Afric Med J. 2009;99(8):579–583.
  • Tessua KK, Munseri P, SSJPo M. Outcomes within a year following first ever stroke in Tanzania. PLoS One. 2021;16(2):e0246492. doi:10.1371/journal.pone.0246492
  • Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44(4):626–634. doi:10.1212/WNL.44.4.626
  • Han J, Mao W, Ni J, et al. Rate and determinants of recurrence at 1 year and 5 years after stroke in a low-income population in rural China. Front Neurol. 2020;11:2. doi:10.3389/fneur.2020.00002
  • Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005;28(2):355–359. doi:10.2337/diacare.28.2.355
  • Callahan A. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Arch Neurol. 2011;68(10):1245–1251. doi:10.1001/archneurol.2011.146